Kareim Oliphant

Represented an Atlanta online fitness startup in connection with its $1.1 million Series Seed Preferred Stock financing transaction to grow its team and expand its customer base.

Represented a New Orleans biotech startup in connection with its $4.5 million Series A Preferred Stock financing transaction to further develop the drug development pipeline relating to a variety of medical fields, including diabetes, oncology and regenerative medicine.

Represented a Nashville-based medical technology cloud platform in connection with the sale of its outstanding shares of capital stock for $33 million to an enterprise health care operations company.

Represented an online agricultural retail platform in connection with its $3 million Series A Preferred Stock financing transaction.

Represented a designer and producer of technology accessories in connection with the sale of its outstanding shares of capital stock for $25 million to a private equity company.

Represented a clean energy technology company in connection with its $12 million Series A Preferred Stock financing transaction.

Represented Martin Ventures where Martin Ventures was lead investor or co-investor in the purchase of debt and equity securities in the following transactions:

• Interactive Health Centers, a company that enables health care providers to offer specialized psychiatric and behavioral health services via telehealth.
• Interactive Life Network, a nationally recognized treatment center for mental health, addiction and intimacy disorders.
• Mployer Advisor, a company that enables employers to find the best benefits and insurance for their unique needs at a competitive price.

Represented Mountain Group Partners where Mountain Group was lead investor in the purchase of debt and equity securities in the following transactions:

• AngelEye Health, Inc., a company that has developed internet-based camera systems and educational and clinical communications software to transform neonatal care.
• In the Bowl Animal Health, Inc., a company that provides pet owners with a creative alternative to current methods of drug administration.

Represented a software-as-a-service (SaaS) provider in the $23 million sale of all its capital stock to a private equity buyer.